Verdict - Living Registry
Status · AI Voice & TTS  /  Vol. 03  /  2026

Is Rime AI still around? (2026)

Yes. Rime AI is live and reachable, price-verified as of Jul 20, 2026.

Status LiveCustom pricingFree tierVerified Jul 20, 2026Category · AI Voice & TTS
§00

What Rime AI is

What sets it apart usage-based per-character pricing with self-host and HIPAA/SOC 2 deployment options

Rime AI is a text-to-speech API built for enterprise voice agents, offering 600+ voices across 50+ languages with controls over pronunciation, pace, and tone. It targets sub-100ms latency for real-time conversation and can be reached through an API or self-hosted, with cloud, on-prem, and VPC deployment options on its Enterprise tier. The Starter plan is usage-based at $0.05 per 1,000 characters with free minutes to start, while Enterprise moves to volume pricing and adds unlimited custom voice clones, SLAs, and BAA (HIPAA) and SOC 2 compliance. It fits teams building conversational applications in banking, healthcare, and customer service.

Sources Rime AI home · Rime AI pricing

§01

Use it, or see the field

Rime AI is live and price-verified as of Jul 20, 2026. If it fits, go straight to it. If you are comparing, see the full ranked field in AI Voice & TTS - only tools our health checks report as alive.

Visit Rime AI
§02

If you want options

§03

Get told if Rime AI's status changes

We email you the moment a new dated, sourced fact lands on Rime AI - a price hike, a shutdown notice, or a confirmed outage. No predictions.

Double opt-in - we email you a confirm link. Only your email is stored, never your IP.
§04

Straight answers

Is Rime AI shutting down?
There is no official sunset announcement for Rime AI as of Jul 20, 2026. It is reachable and price-verified; a "dead" status is set only by an editor, never by an automated check.
How much does Rime AI cost?
Rime AI uses custom or quote-based pricing as of Jul 20, 2026; there is no published fixed monthly plan.
Does Rime AI have a free tier?
Yes, Rime AI offers a permanent free plan (not just a trial) as of Jul 20, 2026.